IGI Logo

Jubilant Pharmova is currently trading at Rs. 716.00, up by 12.10 points or 1.72% from its previous closing of Rs. 703.90 on the BSE.

The scrip opened at Rs. 700.00 and has touched a high and low of Rs. 733.00 and Rs. 696.25 respectively. So far 18941 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 740.80 on 17-May-2024 and a 52 week low of Rs. 318.50 on 30-May-2023.

Last one week high and low of the scrip stood at Rs. 733.00 and Rs. 687.10 respectively. The current market cap of the company is Rs. 11313.74 crore.

The promoters holding in the company stood at 50.68%, while Institutions and Non-Institutions held 22.83% and 26.49% respectively.

Jubilant Pharmova’s wholly-owned subsidiary -- Jubilant Biosys has approved the proposal for investment including entering into a Power Supply and Offtake Agreement, and Share Subscription and Shareholders Agreement on May 28, 2024 with Isharays Energy Two (Isharays Energy), a wholly-owned subsidiary of SunSource Energy, for acquisition of upto 14.75% stake of Isharays Energy for purchase of renewable energy (electricity) generated from the Captive Generating Plant (CGP).

The company has embarked on a renewable energy implementation journey across its facilities in India to enable reduction in both, cost and carbon footprint. This investment shall enable the company to access renewable energy through captive power arrangement for its facilities located in Noida and Greater Noida. In January this year, the company had approved a similar investment to access renewable power through captive arrangement for its facilities located in Karnataka, India.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.